{"changes":[],"country":"US","description":"Extend Biosciences develops a vitamin D-conjugate platform that extends the half-life of peptide and small-molecule therapeutics. It serves rare endocrine disease patients and pharma partners licensing the conjugate platform. The DVITA technology binds drugs to circulating vitamin D-binding protein, extending dosing intervals from days to weeks.","domain":"extendbiosciences.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":30.811899,"lng":-93.740504,"location":"Newton, USA","name":"Extend Biosciences INC","rounds":[{"amountQuarantined":false,"amountUsd":2000000,"currency":"USD","date":"2024-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"strategic","url":null}],"slug":"extendbiosciences-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"extendbiosciences.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://extendbiosciences.com"},{"fact":"description","publisher":"extendbiosciences.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://extendbiosciences.com"}],"stage":"series-b+","techStack":[],"totalRaisedUsd":1999230,"updatedAt":"2026-05-02"}